PPD Inc
Las Vegas, Nevada, 89113, United States
NCT Number: NCT06659263
The purpose of this study is to obtain data necessary to characterize the elimination of RE104 and metabolites from breastmilk of health lactating volunteers to support a regulatory assessment of when mothers can safely return to breastfeeding following a single-dose of RE104 for Injection.
Looking for future studies?
Notify Me18 year–45 year
Female
Interventional
Phase 1
Las Vegas, Nevada, 89113, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Single, subcutaneous dose of RE104 for Injection
Time frame: Through 24 hours postdose
Time frame: Through 168 hours postdose
Time frame: Through 168 hours postdose
Time frame: Through 168 hours postdose
Time frame: Through 168 hours postdose
Time frame: Through 168 hours postdose
Time frame: Through 168 hours postdose
Time frame: Through 168 hours postdose
Time frame: Through 72 hours postdose
Time frame: Through 168 hours postdose
Time frame: From dosing through study completion (post-dose follow-up is for 14 days)
A treatment-emergent adverse event (TEAE) is defined as any unfavorable and unintended sign, symptom or disease temporally associated with the use of a study drug.
Time frame: Through 24 hours postdose
Time frame: Through 168 hours postdose
Time frame: Through 168 hours postdose
Time frame: Through 168 hours postdose
Time frame: Through 168 hours postdose
Time frame: Through 168 hours postdose
Time frame: Through 168 hours postdose
Time frame: 1, 3 and 8 hours post-dose
Reunion Neuroscience Inc
Industry
A Phase 1, Open-label, Single Dose Study to Evaluate the Concentration of RE104 and Its Major Metabolites in Breast Milk and Plasma of Healthy Lactating Women.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07481643
Anxiety, Anxiety Disorders
Aydin, Aydın, Turkey (Türkiye)
View Trial DetailsNCT07427706
Apgar Score, Behavior
Tarragona, Reus, Spain
View Trial DetailsNCT07336186
Behavior, Breast Feeding
Kocaeli, İzmit, Turkey (Türkiye)
View Trial DetailsNCT06816901
Behavior, Breast Feeding
Janakpur Dham, Dhanusha District, Nepal
View Trial Details